Editor’s Note: This page is a companion page to the main article, “Survey: Staffing woes ease slightly, but challenges remain.”
With the explosion of GLP-1–based therapies for type 2 diabetes…
Growth is the goal in any ASC—growth in volume, growth…
Editor’s Note: This page is a companion piece to the…